Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 223

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 223
---
 by the CODM for the period commencing July 24 through December
31, 2024, for the period commencing January 1, 2024 through July 23, 2024 and for the year ended December 31, 2023:

|                             |     | Successor 
 2024      | For the period commencing July 24, 
                            through 
                       December 31, |     | Predecessor 
 2024        | For the period commencing January 1, 
                              through 
                             July 23, |     | 2023 |   Year ended 
 December 31, |
|:----------------------------|:----|:----------|-----------------------------------:|:----|:------------|-------------------------------------:|:----|:-----|-------------:|
| Clinical developments       |     |           |                                171 |     |             |                                  354 |     |      |          490 |
| Payroll expenses            |     |           |                                321 |     |             |                                   98 |     |      |          151 |
| Professional services       |     |           |                                283 |     |             |                                  131 |     |      |          148 |
| Other segments expenses (*) |     |           |                              1,309 |     |             |                                  838 |     |      |          198 |
|                             |     |           |                              2,084 |     |             |                                1,421 |     |      |          987 |

| (*) | Other segments expenses includes share based compensation and other 
 expenses.                                                           |

<div align='center'>F-33

REVIUM RX.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2025

UNAUDITED

U.S. DOLLARS IN THOUSANDS

INDEX</div>

|                                                         |     | Page         |
| Condensed Consolidated Balance Sheets                   |     | F-35         |
| Condensed Consolidated Statements of Comprehensive Loss |     | F-36         |
| Condensed Consolidated Statements of Changes in Equity  |     | F-37         |
| Condensed Consolidated Statements of Cash Flows         |     | F-39         |
| Notes to Condensed Consolidated Financial Statements    |     | F-40 –  F-44 |

<div align='center'>- - - - - - - - - - -

F-34</div